A 34-year-old man was referred to our hospital with gastric polypoid lesions and biopsy-confirmed neuroendocrine tumor (NET). Computed tomography (CT) revealed a 3×3.5×8-cm retroperitoneal mass behind the pancreas, with multiple hepatic metastases. His serum gastrin level was elevated to 1,396 pg/mL. We performed a wedge resection of the stomach, a right hemi-hepatectomy, and a retroperitoneal mass excision. After careful review of the clinical, radiological, histopathological, and immunohistochemical findings, peripancreatic gastrinoma, and synchronous gastric NET were ultimately diagnosed. We reviewed a CT scan that had been performed 6 years previously after surgery for a duodenal perforation. There was no evidence of gastric or hepatic lesions, but the retroperitoneal mass was present at the same site. Had gastrinoma been detected earlier, our patient could have been cured using less invasive treatment. This case demonstrates how important it is to consider Zollinger-Ellison syndrome in patients with a recurrent or aggressive ulcer.
Citations
Citations to this article as recorded by
Laparoscopic Excision of Primary Lymph Node Gastrinoma: A Case Report and Review of Literature Dhananjaya Sharma, Sanjay Kumar Yadav, Bharath Shiva, M Mohammed Imran, Pradeep Kumar Kothiya Indian Journal of Endocrine Surgery and Research.2025; 20(1): 29. CrossRef
Current Medical Controversies in Zollinger–Ellison Syndrome Robert T. Jensen, Irene Ramos-Alvarez, Jeffrey A. Norton Biomedicines.2025; 13(12): 3051. CrossRef
Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome Lingaku Lee, Irene Ramos-Alvarez, Tetsuhide Ito, Robert T. Jensen International Journal of Molecular Sciences.2019; 20(20): 5128. CrossRef
Diagnosis of Zollinger–Ellison Syndrome in the Era of Ppis, Faulty Gastrin Assays, Sensitive Imaging and Limited Access to Acid Secretory Testing David C Metz, Guillaume Cadiot, Pierre Poitras, Tetsuhide Ito, Robert T Jensen International Journal of Endocrine Oncology.2017; 4(4): 167. CrossRef
Efficacy, safety, and tolerability of a ready-to-drink bowel preparation in overweight and obese adults: subanalysis by body mass index from a phase III, assessor-blinded study Lawrence Hookey, Gerald Bertiger, Kenneth Lee Johnson, Mena Boules, Masakazu Ando, David N. Dahdal Therapeutic Advances in Gastroenterology.2020;[Epub] CrossRef